title: Use of hormone replacement therapy and the risk of colorectal cancer.
abstract: OBJECTIVE
  Estrogen/progestin replacement therapy is prescribed to women in menopause for purposes of postmenopausal symptom control or prevention of hormone deficiency-related diseases such as osteoporosis. Such treatments have formerly been shown to be associated with lower colorectal cancer risk in an as yet unknown mechanism.
  
  
  METHODS
  The Molecular Epidemiology of Colorectal Cancer study was a population-based case-control study in northern Israel of patients with colorectal cancer who were diagnosed between 1998 and 2006, and age-, sex-, clinic-, and ethnicity-matched population controls. Use of hormone replacement therapy (HRT) was assessed using a structured interview and validated by studying prescription records in a subset of patients for whom they were available.
  
  
  RESULTS
  Two thousand four hundred sixty peri/postmenopausal women were studied from among 2,648 patients with colorectal cancer and 2,566 controls. The self-reported use of HRT was associated with a significantly reduced relative risk of colorectal cancer (odds ratio [OR], 0.67; 95% CI, 0.51 to 0.89). This association remained significant after adjustment for age, sex, use of aspirin and statins, sports activity, family history of colorectal cancer, ethnic group, and level of vegetable consumption (OR, 0.37; 95% CI, 0.22 to 0.62). Statistically significant interactions were seen between use of HRT and use of aspirin and involvement in sports activity. Using pharmacy data, only users of combined oral preparations demonstrated a significant negative association with colorectal cancer.
  
  
  CONCLUSIONS
  The use of oral HRT was associated with a 63% relative reduction in the risk of colorectal cancer in postmenopausal women after adjustment for other known risk factors. This effect was not found in aspirin users and women with intensive sports participation.
authors.affiliation: Department of Community Medicine and Epidemiology, Carmel Medical Center, 7 Michal St, Haifa 34362, Israel. rennert@tx.technion.ac.il
authors.forename: Gad
authors.initials: G
authors.lastname: Rennert
authors.forename: Hedy S
authors.initials: HS
authors.lastname: Rennert
authors.forename: Mila
authors.initials: M
authors.lastname: Pinchev
authors.forename: Ofer
authors.initials: O
authors.lastname: Lavie
authors.forename: Stephen B
authors.initials: SB
authors.lastname: Gruber
mesh_terms: D000368:Aged; D015179:Colorectal Neoplasms / Q000453:epidemiology* / Q000517:prevention & control; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D047648:Perimenopause; D017698:Postmenopause; D012307:Risk Factors
references.citation: JAMA. 2002 Aug 21;288(7):872-81
references.pmid: 12186605
references.citation: JAMA. 2005 Jan 19;293(3):330-9
references.pmid: 15657326
references.citation: Am J Gastroenterol. 2005 Aug;100(8):1813-20
references.pmid: 16086719
references.citation: N Engl J Med. 2004 Mar 4;350(10):991-1004
references.pmid: 14999111
references.citation: Dis Colon Rectum. 2005 Dec;48(12):2317-21
references.pmid: 16228836
references.citation: PLoS Med. 2007 May;4(5):e157
references.pmid: 17518513
references.citation: Br J Cancer. 2004 Jan 12;90(1):76-81
references.pmid: 14710210
references.citation: JAMA. 2004 Apr 14;291(14):1701-12
references.pmid: 15082697
references.citation: Osteoporos Int. 1998;8(6):540-6
references.pmid: 10326058
references.citation: BMJ. 2008 Jul 10;337:a386
references.pmid: 18617493
references.citation: Hum Reprod. 2007 Jun;22(6):1769-77
references.pmid: 17347166
references.citation: Br J Cancer. 2007 Dec 3;97(11):1486-92
references.pmid: 17987040
references.citation: CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
references.pmid: 18287387
references.citation: Int J Cancer. 2003 Jun 20;105(3):408-12
references.pmid: 12704678
references.citation: CMAJ. 2000 May 16;162(10):1421-4
references.pmid: 10834045
references.citation: Gastroenterology. 1993 Jul;105(1):142-7
references.pmid: 8514031
references.citation: Ann Oncol. 2008 Jan;19(1):150-5
references.pmid: 17785762
references.citation: Menopause. 2007 Nov-Dec;14(6):985-94
references.pmid: 17507833
references.citation: Cancer Causes Control. 2005 Oct;16(8):965-73
references.pmid: 16132805
references.citation: Ann Intern Med. 2001 Oct 2;135(7):493-501
references.pmid: 11578152
references.citation: J Aging Phys Act. 2004 Oct;12(4):554-67
references.pmid: 15851826
references.citation: Carcinogenesis. 2008 Sep;29(9):1774-80
references.pmid: 18375958
references.citation: Gastroenterology. 2001 Sep;121(3):542-7
references.pmid: 11522737
references.citation: N Engl J Med. 2005 May 26;352(21):2184-92
references.pmid: 15917383
references.citation: Cancer Causes Control. 2003 Dec;14(10):979-84
references.pmid: 14750537
references.citation: Contraception. 2005 Feb;71(2):95-8
references.pmid: 15707557
references.citation: Lancet. 2002 Sep 21;360(9337):942-4
references.pmid: 12354487
references.citation: Cancer Res. 2001 Jan 1;61(1):126-30
references.pmid: 11196149
references.citation: Cancer Res. 2007 Aug 1;67(15):7534-9
references.pmid: 17671225
references.citation: Obstet Gynecol. 1994 Jan;83(1):5-11
references.pmid: 8272307
references.citation: Int J Vitam Nutr Res. 2007 Nov;77(6):398-405
references.pmid: 18622950
references.citation: Am J Clin Nutr. 1982 Nov;36(5):936-42
references.pmid: 7137077
references.citation: J Cell Mol Med. 2007 Sep-Oct;11(5):1138-48
references.pmid: 17979889
references.citation: Eur J Cancer Prev. 2005 Aug;14(4):373-9
references.pmid: 16030428
references.citation: Cancer Causes Control. 1997 Mar;8(2):146-58
references.pmid: 9134238
references.citation: Obstet Gynecol. 1999 May;93(5 Pt 2):880-8
references.pmid: 10912438